Tranexamic Acid.jpg

Tranexamic acid TXA

Tranexamic acid (TXA), also known by brand names like Amikapron or Cyklokapron, is a synthetic derivative of the amino acid lysine. First discovered in the 1950s and introduced for medical use in 1962, this white, crystalline powder is highly soluble in water and belongs to the class of antifibrinol
Send Inquiry

Products Description

Tranexamic acid (TXA), also known by brand names like Amikapron or Cyklokapron, is a synthetic derivative of the amino acid lysine. First discovered in the 1950s and introduced for medical use in 1962, this white, crystalline powder is highly soluble in water and belongs to the class of antifibrinolytic medications. Its chemical structure allows it to bind tightly to plasminogen and plasmin, key proteins involved in the breakdown of blood clots, thereby preventing excessive bleeding.

 

The primary function of tranexamic acid is to inhibit fibrinolysis, the process by which the body breaks down blood clots. It achieves this by reversibly blocking the lysine-binding sites on plasminogen molecules, preventing their conversion to plasmin. Without plasmin, the enzyme responsible for dissolving fibrin (the main component of blood clots), clots remain stable and intact, effectively stopping bleeding.

 

Beyond its antifibrinolytic properties, tranexamic acid also exhibits anti-inflammatory effects by reducing the release of inflammatory mediators like prostaglandins and leukotrienes. In dermatology, it interferes with melanin production by inhibiting tyrosinase activity and blocking the transfer of melanosomes to skin cells, making it a popular ingredient in skincare products targeting hyperpigmentation.

 

Medical Applications

Trauma and Emergency Medicine

Tranexamic acid is a cornerstone in the management of traumatic bleeding. The landmark CRASH-2 trial demonstrated that administering TXA within three hours of injury significantly reduces mortality in trauma patients with significant bleeding. It is now included in international guidelines for the treatment of major trauma, including road accidents, falls, and combat injuries. The drug helps stabilize blood clots in damaged blood vessels, reducing the need for blood transfusions and improving patient outcomes.

 

Surgical Procedures

In surgical settings, tranexamic acid is used to minimize blood loss during both elective and emergency surgeries. It is particularly beneficial in procedures with high bleeding risks, such as cardiac surgery, orthopedic joint replacements, and spinal surgeries. By reducing intraoperative bleeding, TXA decreases the likelihood of transfusion-related complications and shortens hospital stays. It is also used in gynecological surgeries, including hysterectomies, to control excessive bleeding.

 

Obstetrics and Gynecology

Tranexamic acid plays a crucial role in managing obstetric hemorrhage, a leading cause of maternal mortality worldwide. It is used to treat bleeding during childbirth, postpartum hemorrhage, and miscarriage. Additionally, it is an effective treatment for heavy menstrual bleeding (menorrhagia), reducing blood loss by up to 50% in women with this condition. Unlike hormonal treatments, TXA does not affect fertility or cause hormonal side effects, making it a preferred option for many patients.

 

Hematological Disorders

Patients with bleeding disorders such as hemophilia or von Willebrand disease often benefit from tranexamic acid. It helps prevent excessive bleeding during dental procedures, surgeries, and other invasive treatments. The drug is also used to manage bleeding in patients with thrombocytopenia (low platelet counts) or those undergoing chemotherapy, who are at increased risk of bleeding due to bone marrow suppression.

 

Ophthalmology

In ophthalmology, tranexamic acid is used to treat bleeding in the eye, including hyphema (bleeding into the anterior chamber) and vitreous hemorrhage. It helps stabilize blood clots and rebleeding, preserving vision and reducing the need for surgical intervention. The drug can be administered orally, intravenously, or topically as eye drops.

 

Dermatological Applications

Melasma and Hyperpigmentation

Tranexamic acid has gained significant popularity in dermatology for its ability to treat melasma, a common skin condition characterized by dark, irregular patches on the face. It works by inhibiting melanin production and reducing the activity of melanocytes, the cells responsible for skin pigmentation. Clinical studies have shown that both oral and topical formulations of TXA can significantly lighten melasma patches, with minimal side effects compared to other treatments like hydroquinone.

 

Post-Inflammatory Hyperpigmentation

Post-inflammatory hyperpigmentation (PIH), which occurs after skin injuries, acne, or inflammatory conditions, can also be effectively treated with tranexamic acid. The drug reduces inflammation and inhibits melanin synthesis, helping to fade dark spots and restore even skin tone. Topical TXA formulations are particularly useful for localized PIH, while oral treatment may be recommended for more widespread pigmentation issues.

 

Acne and Rosacea

Tranexamic acid's anti-inflammatory properties make it a promising treatment for acne and rosacea. It reduces redness, swelling, and inflammation associated with these conditions, improving overall skin appearance. In acne treatment, TXA can be used alone or in combination with other medications like benzoyl peroxide or retinoids to enhance efficacy.

 

Scar Lightening

Recent studies have shown that tranexamic acid can help lighten and improve the appearance of scars, including surgical scars and acne scars. It reduces inflammation and inhibits melanin production in scar tissue, making scars less visible over time. Topical TXA gels or creams are often used in conjunction with other scar treatments like silicone sheets or laser therapy for optimal results.

 

Skincare Products

Tranexamic acid is increasingly being incorporated into skincare products due to its gentle yet effective brightening properties. It is commonly found in serums, creams, masks, and toners designed to target hyperpigmentation, dark spots, and uneven skin tone. Unlike some other brightening ingredients, TXA is well-tolerated by most skin types, including sensitive skin, and does not cause irritation or photosensitivity.

 

When used in skincare, tranexamic acid typically ranges in concentration from 2% to 5%. Higher concentrations may be used in prescription-strength products, but over-the-counter formulations with 2-3% TXA can still provide noticeable results with regular use. It is often combined with other skincare ingredients like vitamin C, niacinamide, and hyaluronic acid to enhance its brightening and hydrating effects.


Leave Your Message

Leave a message